Loading…
DIA Europe 2019 has ended
Back To Schedule
Thursday, February 7 • 15:15 - 16:15
Conference Closer- Rapid Fire Session

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
This must-attend ‘Rapid Fire’ session is an excellent opportunity to hear what you have missed in the sessions that you could not attend! Topic Leaders will have 4 minutes onstage to share the essence from the presentations and discussions in their topics by delivering summaries of novel insights and key takeaways from the DIA Europe meeting. DIA is capturing emerging knowledge and insights in order to advance selected topics after the meeting.

Moderator:
Thomas Bols, SVP and Managing Director DIA EMEA
Speakers
avatar for Claudine Sapède

Claudine Sapède

Global HTA and Payment Policy Lead, F. Hoffmann-La Roche
Claudine Sapède is Global HTA and Payment Policy Lead at Roche based in Basel. She works on the development of Roche’s external policy positions and projects on market access related subjects including HTA and pricing. She has been working in the field of reimbursement, market... Read More →
avatar for Robert Hemmings

Robert Hemmings

Statistics and Pharmacokinetics Unit Manager, Medicines and Healthcare products Regulatory Agency (MHRA)
Rob has been with MHRA for 16 years and heads up the team of statisticians and pharmacokineticists. Much of Rob’s time is spent educating colleagues in the importance and artistry of clinical trial statistics; their use in proof and in obfuscation. Rob is a co-opted member of the... Read More →
avatar for João Duarte

João Duarte

Director, Business Planning & Operations, Global Regulatory Affairs, R&D and Com, Alexion, Astrazeneca Rare Disease, France
João Duarte is currently Director, Business Planning & Operations at Alexion, AstraZenenca Rare Disease. João serves as Chief of Staff to the Head of Regulatory & Quality Affairs and leads regulatory policy activities within the team. He held several roles since 2012 in Regulatory... Read More →
EH

Esteban Herrero-Martinez

Director Regulatory Policy and Intelligence, Abbvie Ltd
Previously Director of Regulatory Intelligence and Policy at Daiichi Sankyo Development Ltd, lead for Pharmacovigilance & Regulatory Affairs at the Association of the British Pharmaceutical Industry (ABPI) and Pharmacovigilance Manager at P&G Pharmaceuticals. Education: Biochemistry... Read More →
avatar for Gaby Danan

Gaby Danan

Pharmacovigilance Expert, NA
Gaby Danan, MD, PhD, was the EU Qualified Person for Pharmacovigilance for Sanofi until his 2010 retirement. He has served on the Council for International Organizations of Medical Sciences and International Council on Harmonisation Expert Working Groups, especially as the European... Read More →
avatar for Chris Walker

Chris Walker

Vice President, European Head of Regulatory Affairs, Amgen Ltd
Chris Walker (MSc RA & BSc Hons), is Head of Regulatory Affairs for Europe for Amgen and Head of the UK R&D sites.. Chris is chair of the Digital Health Taskforce at EFPIA, a member of the Innovation BSC & Regulatory Strategy Groups. Chris leads the regulatory strategy team for Amgen’s... Read More →
avatar for Danie Du Plessis

Danie Du Plessis

Managing Director and Owner, The Next Version
After completing his medical studies and a Master’s Degree in Pharmacology in South Africa, Danie spent 3 years working in a primary care setting including his own private practice. He joined the pharmaceutical industry in 1991 and held roles of increasing responsibility and leadership... Read More →

Thursday February 7, 2019 15:15 - 16:15 CET
F2 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  Conference Closer